دورية أكاديمية
Efficacy and tolerability of Brivaracetam in people with intellectual disability compared to those without intellectual disability.
| العنوان: | Efficacy and tolerability of Brivaracetam in people with intellectual disability compared to those without intellectual disability. |
|---|---|
| المؤلفون: | Allard, Jon, Henley, William, Sellers, Adrian, O'Shaughnessy, Emma, Thomson, Oliver, McLean, Brendan, Parrett, Mary, Rajakulendran, Sanjeev, Watkins, Lance, Maguire, Melissa, Ellawela, Shan, Tittensor, Phil, Sen, Arjune, Mohanraj, Rajiv, Bagary, Manny, Ram, Sunil, Brown, Allan, Shankar, Rohit |
| المصدر: | Epilepsy Behav ; ISSN:1525-5069 ; Volume:158 |
| بيانات النشر: | Elsevier Science |
| سنة النشر: | 2024 |
| المجموعة: | PubMed Central (PMC) |
| الوصف: | In England, nearly a quarter of people with intellectual disability (PwID) have epilepsy. Though 70 % of PwID have pharmaco-resistant seizures only 10 % are prescribed anti-seizure medication (ASMs) licenced for pharmaco-resistance. Brivaracetam (BRV) licenced in 2016 has had nine post-marketing studies involving PwID. These studies are limited either by lack of controls or not looking at outcomes based on differing levels of ID severity. This study looks at evidence comparing effectiveness and side-effects in PwID to those without ID prescribed Brivaracetam (BRV). |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| العلاقة: | https://doi.org/10.1016/j.yebeh.2024.109906Test; https://pubmed.ncbi.nlm.nih.gov/38936308Test |
| DOI: | 10.1016/j.yebeh.2024.109906 |
| الإتاحة: | https://doi.org/10.1016/j.yebeh.2024.109906Test https://pubmed.ncbi.nlm.nih.gov/38936308Test |
| حقوق: | Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved. |
| رقم الانضمام: | edsbas.B528662F |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.yebeh.2024.109906 |
|---|